Drugs / DTG
last change Jan 2025 re-read 2 minutes ago

DTG

Developed for
HIV infectious disease
Investigated by
Institute of Pathogen Biology, Beijing, China · Shanxi Kangbao Biological Product Co., Ltd.

Trials 1 · a red edge is where a trial was stopped

202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT06061536 Nov 2023 → Nov 2024 HIV infectious disease Shanxi Kangbao Biological Product Co., Ltd. Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as DTG ClinicalTrials.gov intervention name — accepted as the source's own label NCT06061536